Epidemiology of haemodialysis outcomes DOI Creative Commons
Aminu K. Bello, Ikechi G. Okpechi, Mohamed A. Osman

et al.

Nature Reviews Nephrology, Journal Year: 2022, Volume and Issue: 18(6), P. 378 - 395

Published: Feb. 22, 2022

Haemodialysis (HD) is the commonest form of kidney replacement therapy in world, accounting for approximately 69% all and 89% dialysis. Over last six decades since inception HD, dialysis technology patient access to have advanced considerably, particularly high-income countries. However, HD availability, accessibility, cost outcomes vary widely across world and, overall, rates impaired quality life, morbidity mortality are high. Cardiovascular disease affects more than two-thirds people receiving major cause accounts almost 50% mortality. In addition, patients on high symptom loads often under considerable financial strain. Despite many advances delivery systems that been achieved treatment was first developed, poor among remain a public health concern. Understanding epidemiology outcomes, why they might different populations how be improved therefore crucial, although this goal hampered by heterogeneity monitoring reporting these settings. This Review examines haemodialysis — clinical, patient-reported surrogate regions populations, including vulnerable individuals. The authors also discuss current status potential strategies improvement.

Language: Английский

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation DOI Open Access
Jean‐Philippe Collet, Hölger Thiele, Emanuele Barbato

et al.

European Heart Journal, Journal Year: 2020, Volume and Issue: 42(14), P. 1289 - 1367

Published: July 10, 2020

A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895

Language: Английский

Citations

4214

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up DOI Creative Commons
Behnood Bikdeli, Mahesh V. Madhavan, David Jiménez

et al.

Journal of the American College of Cardiology, Journal Year: 2020, Volume and Issue: 75(23), P. 2950 - 2973

Published: April 17, 2020

Language: Английский

Citations

2834

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic DOI Creative Commons
Elissa Driggin, Mahesh V. Madhavan, Behnood Bikdeli

et al.

Journal of the American College of Cardiology, Journal Year: 2020, Volume and Issue: 75(18), P. 2352 - 2371

Published: March 19, 2020

Language: Английский

Citations

1992

2023 ESC Guidelines for the management of acute coronary syndromes DOI Open Access
Robert A. Byrne, Xavier Rosselló, J J Coughlan

et al.

European Heart Journal, Journal Year: 2023, Volume and Issue: 44(38), P. 3720 - 3826

Published: Aug. 25, 2023

Language: Английский

Citations

1904

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines DOI Open Access
Martha Gulati, Phillip D. Levy, Debabrata Mukherjee

et al.

Circulation, Journal Year: 2021, Volume and Issue: 144(22)

Published: Oct. 28, 2021

Aim: This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations algorithms clinicians to assess diagnose in adult patients. Methods: A comprehensive literature search was conducted from November 11, 2017, May 1, 2020, encompassing randomized nonrandomized trials, observational studies, registries, reviews, other evidence on human subjects that were published English PubMed, EMBASE, Cochrane Collaboration, Agency Healthcare Research Quality reports, relevant databases. Additional through April 2021, also considered. Structure: Chest is a frequent cause emergency department visits United States. The “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline Evaluation Diagnosis Pain” based contemporary assessment pain. presents an evidence-based approach risk stratification diagnostic workup Cost-value considerations testing have been incorporated, shared decision-making with patients recommended.

Language: Английский

Citations

1175

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases DOI Open Access

Griselda A. Cabral-Pacheco,

Idalia Garza‐Veloz, Claudia Castruita-De la Rosa

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(24), P. 9739 - 9739

Published: Dec. 20, 2020

Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component ECM. The degradation ECM is great importance, since it related embryonic development and angiogenesis. It also involved in cell repair tissues. When expression MMPs altered, can generate abnormal This initial cause chronic degenerative diseases vascular complications generated by diabetes. In addition, this process has an association with neurodegeneration cancer progression. Within ECM, tissue inhibitors (TIMPs) inhibit proteolytic activity MMPs. TIMPs important regulators turnover, remodeling, cellular behavior. Therefore, (similar MMPs) modulate angiogenesis, proliferation, apoptosis. An interruption balance between been implicated pathophysiology progression several diseases. review focuses on participation both (e.g., MMP-2 MMP-9) TIMP-1 TIMP-3) physiological processes how their regulation associated human inclusion current strategies mechanisms MMP inhibition new therapies targeting was considered.

Language: Английский

Citations

1145

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research DOI Creative Commons
Philippe Généreux, Nicolò Piazza, Maria Alu

et al.

Journal of the American College of Cardiology, Journal Year: 2021, Volume and Issue: 77(21), P. 2717 - 2746

Published: April 20, 2021

Language: Английский

Citations

743

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection DOI Creative Commons
Anuradha Lala, Kipp W. Johnson, James L. Januzzi

et al.

Journal of the American College of Cardiology, Journal Year: 2020, Volume and Issue: 76(5), P. 533 - 546

Published: June 8, 2020

Language: Английский

Citations

689

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease DOI Open Access
Gregg W. Stone, A. Pieter Kappetein, Joseph F. Sabik

et al.

New England Journal of Medicine, Journal Year: 2019, Volume and Issue: 381(19), P. 1820 - 1830

Published: Sept. 28, 2019

Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents, as compared coronary-artery bypass grafting (CABG), in patients left main artery disease are not clearly established.

Language: Английский

Citations

647

Universal Definition and Classification of Heart Failure DOI Open Access
Biykem Bozkurt, Andrew J.S. Coats, Hiroyuki Tsutsui

et al.

Journal of Cardiac Failure, Journal Year: 2021, Volume and Issue: 27(4), P. 387 - 413

Published: March 1, 2021

Language: Английский

Citations

622